author-photo

P. Klöpfer

MorphoSys

3

Papers

0

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY TO ASSESS SAFETY OF TAFASITAMAB OR TAFASITAMAB + LENALIDOMIDE IN ADDITION TO R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
First-Mind: A phase IB, open-label, randomized study to assess safety of tafasitamab or tafasitamab + lenalidomide in addition to r-chop in patients with newly diagnosed DLBCL

2021
Show All
- Source
- Cite
- Save
Citations (0)
First-MIND: A phase Ib, open-label, randomized study to assess safety of tafasitamab (TAFA) or TAFA + lenalidomide (LEN) in addition to R-CHOP in patients with newly diagnosed DLBCL

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)